News
OPHLY
4.560
NaN%
--
Weekly Report: what happened at OPHLY last week (0601-0605)?
Weekly Report · 2d ago
Weekly Report: what happened at OPHLY last week (0525-0529)?
Weekly Report · 06/01 10:41
Weekly Report: what happened at OPHLY last week (0518-0522)?
Weekly Report · 05/25 10:45
Weekly Report: what happened at OPHLY last week (0511-0515)?
Weekly Report · 05/18 10:45
Weekly Report: what happened at OPHLY last week (0504-0508)?
Weekly Report · 05/11 10:41
Ono Pharmaceutical reports FY results
Seeking Alpha · 05/08 09:55
Weekly Report: what happened at OPHLY last week (0427-0501)?
Weekly Report · 05/04 10:37
Weekly Report: what happened at OPHLY last week (0420-0424)?
Weekly Report · 04/27 10:41
Weekly Report: what happened at OPHLY last week (0413-0417)?
Weekly Report · 04/20 10:36
Weekly Report: what happened at OPHLY last week (0406-0410)?
Weekly Report · 04/13 10:41
Weekly Report: what happened at OPHLY last week (0330-0403)?
Weekly Report · 04/06 10:41
Weekly Report: what happened at OPHLY last week (0323-0327)?
Weekly Report · 03/30 10:42
Weekly Report: what happened at OPHLY last week (0316-0320)?
Weekly Report · 03/23 10:37
Weekly Report: what happened at OPHLY last week (0309-0313)?
Weekly Report · 03/16 10:36
Weekly Report: what happened at OPHLY last week (0302-0306)?
Weekly Report · 03/09 10:37
Weekly Report: what happened at OPHLY last week (0223-0227)?
Weekly Report · 03/02 10:36
Pfizer wins full FDA approval for Braftovi in colorectal cancer
Seeking Alpha · 02/24 18:26
Weekly Report: what happened at OPHLY last week (0216-0220)?
Weekly Report · 02/23 10:36
Pfizer says cancer therapy Braftovi improved survival in late-stage trial
Seeking Alpha · 02/17 14:11
Weekly Report: what happened at OPHLY last week (0209-0213)?
Weekly Report · 02/16 10:36
More
Webull provides a variety of real-time OPHLY stock news. You can receive the latest news about Ono Pharmace Drc through multiple platforms. This information may help you make smarter investment decisions.
About OPHLY
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.